Summary | Issuer | Wockhardt Bio AG | | Reason for Disclosing | Capital Increase | | Basis of Calculation | 51,948,000 | | Acquisition Positions | 49,600,000 (95.480 %) | | Disposal Positions | 0 (0.000 %) | | Date of Origination of the Reporting Obligation | 09/18/2015 | | | | Group | Beneficial Owners | - Dr Habil Fakhruddin, Khorakiwala, Mumbai, IN
- Gruppe Wockhardt Ltd, Mumbai, IN
| | Type of Understanding | Shareholder Agreement | | Direct Shareholder(s) | Representation of the Group | | | Dr Habil Fakhruddin Khorakiwala, Mumbai, IN | | |
